In response

Affiliations

¹ Department of Medical Oncology, Cancer Institute/Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing Key Laboratory of Clinical Study on Anticancer Molecular Targeted Drugs, Beijing, China.
² Department of Internal Medicine, National Taiwan University College of Medicine, National Taiwan University, Taipei, Taiwan. Electronic address: pcyang@ntu.edu.tw.

Free article

Comment

Yuankai Shi et al. J Thorac Oncol. 2014 Jul.

Free article

. 2014 Jul;9(7):e58-e59.

doi: 10.1097/JTO.0000000000000237.

¹ Department of Medical Oncology, Cancer Institute/Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing Key Laboratory of Clinical Study on Anticancer Molecular Targeted Drugs, Beijing, China.
² Department of Internal Medicine, National Taiwan University College of Medicine, National Taiwan University, Taipei, Taiwan. Electronic address: pcyang@ntu.edu.tw.

No abstract available

Comment on

A prospective, molecular epidemiology study of EGFR mutations in Asian patients with advanced non-small-cell lung cancer of adenocarcinoma histology (PIONEER).
Shi Y, Au JS, Thongprasert S, Srinivasan S, Tsai CM, Khoa MT, Heeroma K, Itoh Y, Cornelio G, Yang PC. Shi Y, et al. J Thorac Oncol. 2014 Feb;9(2):154-62. doi: 10.1097/JTO.0000000000000033. J Thorac Oncol. 2014. PMID: 24419411 Free PMC article.
To the editor.
Ou SI. Ou SI. J Thorac Oncol. 2014 Jul;9(7):e57-e58. doi: 10.1097/JTO.0000000000000192. J Thorac Oncol. 2014. PMID: 24926558 No abstract available.